Adamed Pharma S.A., Polfarmex S.A.

The medicine is used to inhibit platelet aggregation. It is indicated, among other things, in ischemic heart disease, after a heart attack, in the prevention of complications following cardiac procedures, in the prevention of cerebral ischemia attacks, and in the prevention of deep vein thrombosis in persons who are long-term immobilized.

Dosage form: tablets, enteric-coated

ATC: B01AC06